| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-11 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-11 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-11 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-11 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-10 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-10 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-10 |